AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2012
Mar 1, 2012
30291_dirs_2012-03-01_4e663591-5806-404e-8de4-aa805fd46a08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-02-28
Reporting Person: Gagnon Robert E. (Vice President, Finance)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-28 | Common Stock | S | 835 | $115.03 | Disposed | 4716 | Direct |
| 2012-02-29 | Common Stock | S | 360 | $115.51 | Disposed | 4356 | Direct |
| 2012-02-29 | Common Stock | S | 357 | $115.51 | Disposed | 3999 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6